Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prednisone"" wg kryterium: Temat


Tytuł :
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
Autorzy :
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Free University and Humboldt University of Berlin, Berlin, Germany. Electronic address: .
Buttgereit F; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Free University and Humboldt University of Berlin, Berlin, Germany.
Bernasconi C; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Álvaro-Gracia JM; Hospital General Universitario Gregorio Marañon, Universidad Complutense de Madrid, Spain.
Castro N; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Dougados M; Rheumatology Service, Université Paris-Descartes, Paris, France.
Gabay C; Department of Rheumatology, Hôpital Cochin, Geneva University Hospitals and Geneva School of Medicine, Geneva, Switzerland.
van Laar JM; University Medical Centre Utrecht, Utrecht, Netherlands.
Nebesky JM; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Pethoe-Schramm A; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Salvarani C; Department of Rheumatology and Clinical Immunology, Università di Modena e Reggio Emilia and Azienda unità sanitaria locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Donath MY; Department of Rheumatology, University Hospital Basel, Basel, Switzerland.
John MR; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Pokaż więcej
Corporate Authors :
SEMIRA collaborators
Źródło :
Lancet (London, England) [Lancet] 2020 Jul 25; Vol. 396 (10246), pp. 267-276.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Arthritis, Rheumatoid/*drug therapy
Glucocorticoids/*therapeutic use
Prednisone/*therapeutic use
Remission Induction/*methods
Administration, Intravenous ; Administration, Oral ; Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/therapeutic use ; Arthritis, Rheumatoid/ethnology ; Double-Blind Method ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; France/epidemiology ; Germany/epidemiology ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Humans ; Injections, Subcutaneous ; Italy/epidemiology ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Russia/epidemiology ; Serbia/epidemiology ; Tunisia/epidemiology
Czasopismo naukowe
Tytuł :
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
Autorzy :
Saiz-Rodríguez M; Research Unit, Hospital Universitario de Burgos, Burgos, Spain.
Peña T; Neumology Department, Hospital Universitario de Burgos, Avda Islas Baleares, 3, Burgos, Spain.
Lázaro L; Neumology Department, Hospital Universitario de Burgos, Avda Islas Baleares, 3, Burgos, Spain.
González Á; Gerencia de Atención Primaria de Burgos, Burgos, Spain.
Martínez A; Gerencia de Atención Primaria de Burgos, Burgos, Spain.
Cordero JA; Instituto de Investigación Sanitaria Bioaraba, Vitoria-Gasteiz, Álava, Spain.
Vicente JT; Emergency Department, Hospital Universitario de Burgos, Burgos, Spain.
Richard F; Emergency Department, Hospital Universitario de Burgos, Burgos, Spain.
Coma MJ; Research Unit, Hospital Universitario de Burgos, Burgos, Spain.
de Frutos M; Research Unit, Hospital Universitario de Burgos, Burgos, Spain.
Labrador J; Research Unit, Hospital Universitario de Burgos, Burgos, Spain.; Hematology Department, Hospital Universitario de Burgos, Burgos, Spain.
Pueyo A; Neumology Department, Hospital Universitario de Burgos, Avda Islas Baleares, 3, Burgos, Spain. .
Pokaż więcej
Źródło :
Trials [Trials] 2020 Jul 09; Vol. 21 (1), pp. 632. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :
Clinical Trial Protocol; Letter
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
MeSH Terms :
Ambulatory Care*
Adrenal Cortex Hormones/*administration & dosage
Antiviral Agents/*administration & dosage
Betacoronavirus/*drug effects
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Prednisone/*administration & dosage
Adolescent ; Adrenal Cortex Hormones/adverse effects ; Adult ; Aged ; Antiviral Agents/adverse effects ; Betacoronavirus/pathogenicity ; Coronavirus Infections/diagnosis ; Coronavirus Infections/virology ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/virology ; Prednisone/adverse effects ; Randomized Controlled Trials as Topic ; Severity of Illness Index ; Spain ; Time Factors ; Treatment Outcome ; Young Adult
SCR Disease Name :
COVID-19
SCR Protocol :
COVID-19 drug treatment
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Opinia redakcyjna
Tytuł :
Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis: Protocol for a systematic review.
Autorzy :
Yang H; The Second Clinical Medical College of Guangzhou University of Chinese Medicine.; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine.; Department of Graduate School, Guangzhou University of Chinese Medicine.
Liu D; Department of Graduate School, Guangzhou University of Chinese Medicine.; General Hospital of Southern Theater Command of PLA, Guangzhou.
Hong X; The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen.
Sun H; Traditional Chinese Medicine Hospital, Xinjiang Medical University, Urumqi, China.
Zheng Y; The Second Clinical Medical College of Guangzhou University of Chinese Medicine.; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine.
Yang B; The Second Clinical Medical College of Guangzhou University of Chinese Medicine.; Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine.
Wang W; Department of Graduate School, Guangzhou University of Chinese Medicine.; General Hospital of Southern Theater Command of PLA, Guangzhou.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Jun 19; Vol. 99 (25), pp. e20832.
Typ publikacji :
Comparative Study; Journal Article; Systematic Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Thymectomy*/adverse effects
Thymectomy*/methods
Anti-Inflammatory Agents/*therapeutic use
Myasthenia Gravis/*therapy
Prednisone/*therapeutic use
Anti-Inflammatory Agents/administration & dosage ; Combined Modality Therapy ; Humans ; Myasthenia Gravis/drug therapy ; Myasthenia Gravis/surgery ; Prednisone/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Can docetaxel combined prednisone effectively treat hormone refractory prostate cancer?: A protocol of systematic review and meta-analysis.
Autorzy :
Cheng L; Department of Urology.
Yue CF; Department of Critical Care Medicine, The First Affiliated Hospital of Jiamusi University.
Wang Y; Department of Urology.
Cao HF; Department of Urology.
Dong JF; Department of Pathology, Jiamusi Anorectal Hospital, Jiamusi, China.
Dong LX; Department of Urology.
Chen DY; Department of Urology.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 May 29; Vol. 99 (22), pp. e20367.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Docetaxel/*therapeutic use
Prednisone/*therapeutic use
Prostatic Neoplasms/*drug therapy
Antineoplastic Agents/administration & dosage ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Docetaxel/administration & dosage ; Humans ; Male ; Prednisone/administration & dosage
Czasopismo naukowe
Tytuł :
Kinetics and mechanistic study on degradation of prednisone acetate by ozone.
Autorzy :
He X; Department of Environmental Science, Guangdong Polytechnic of Environmental Protection Engineering, Guangdong Foshan, P.R. China.
Huang H; Department of Environmental Science, Guangdong Polytechnic of Environmental Protection Engineering, Guangdong Foshan, P.R. China.
Tang Y; Department of Environmental Science, Guangdong Polytechnic of Environmental Protection Engineering, Guangdong Foshan, P.R. China.
Guo L; Department of Environmental Science, Guangdong Polytechnic of Environmental Protection Engineering, Guangdong Foshan, P.R. China.
Pokaż więcej
Źródło :
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering [J Environ Sci Health A Tox Hazard Subst Environ Eng] 2020; Vol. 55 (3), pp. 292-304. Date of Electronic Publication: 2019 Nov 26.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Marcel Dekker Country of Publication: England NLM ID: 9812551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4117 (Electronic) Linking ISSN: 10934529 NLM ISO Abbreviation: J Environ Sci Health A Tox Hazard Subst Environ Eng Subsets: MEDLINE
MeSH Terms :
Ozone/*chemistry
Prednisone/*chemistry
Water Pollutants, Chemical/*chemistry
Water Purification/*methods
Acids, Acyclic/chemistry ; Hydrogen-Ion Concentration ; Kinetics ; Mass Spectrometry ; Nanotubes, Carbon/chemistry ; Oxidation-Reduction ; Prednisone/isolation & purification ; Water Pollutants, Chemical/isolation & purification
Czasopismo naukowe
Tytuł :
Improvement of the hematologic toxicities of ruxolitinib in patients with MPN-associated myelofibrosis using a combination of thalidomide, stanozolol and prednisone.
Autorzy :
Duan M; a Department of Hematology , Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , People's Republic of China.
Zhou D; a Department of Hematology , Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , People's Republic of China.
Pokaż więcej
Źródło :
Hematology (Amsterdam, Netherlands) [Hematology] 2019 Dec; Vol. 24 (1), pp. 516-520.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE
MeSH Terms :
Anemia/*chemically induced
Prednisone/*therapeutic use
Primary Myelofibrosis/*drug therapy
Pyrazoles/*adverse effects
Splenomegaly/*prevention & control
Stanozolol/*therapeutic use
Thalidomide/*therapeutic use
Thrombocytopenia/*chemically induced
Adult ; Aged ; Aged, 80 and over ; Anemia/blood ; Anemia/prevention & control ; Anemia/therapy ; Blood Cell Count ; Blood Transfusion ; Drug Evaluation ; Drug Therapy, Combination ; Female ; Hemoglobins/analysis ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Myeloproliferative Disorders/complications ; Prednisone/administration & dosage ; Primary Myelofibrosis/blood ; Primary Myelofibrosis/etiology ; Pyrazoles/administration & dosage ; Pyrazoles/therapeutic use ; Retrospective Studies ; Splenomegaly/etiology ; Splenomegaly/pathology ; Stanozolol/administration & dosage ; Thalidomide/administration & dosage ; Thrombocytopenia/blood ; Thrombocytopenia/prevention & control
Czasopismo naukowe
Tytuł :
Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).
Autorzy :
Birnie D; University of Ottawa Heart Institute, ON, Canada. Electronic address: .
Beanlands RSB; University of Ottawa Heart Institute, ON, Canada.
Nery P; University of Ottawa Heart Institute, ON, Canada.
Aaron SD; University of Ottawa, ON, Canada.
Culver DA; Cleveland Clinic, Cleveland, OH, USA.
DeKemp RA; University of Ottawa Heart Institute, ON, Canada.
Gula L; London Health Sciences Centre, On, Canada.
Ha A; Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.
Healey JS; Hamilton Health Sciences Center, ON, Canada.
Inoue Y; National Cerebral and Cardiovascular Center, Suita, Japan.
Judson MA; Albany Medical College, Albany, New York, USA.
Juneau D; Centre Hospitalier de l'Université de Montréal, Department of Radiology and Nuclear Medicine, Montréal, QC, Canada.
Kusano K; National Cerebral and Cardiovascular Center, Suita, Japan; Libin Cardiovascular Institute of Alberta, Alberta, Canada.
Quinn R; Montreal Heart Institute, Quebec, Canada.
Rivard L; University of British Columbia, Vancouver, British Columbia, Canada.
Toma M; Imperial College Healthcare NHS Trust, London, UK.
Varnava A; Virginia Commonwealth University, Richmond, VA, USA.
Wells G; University of Ottawa Heart Institute, ON, Canada.
Wickremasinghe M; Virginia Commonwealth University, Richmond, VA, USA.
Kron J; Virginia Commonwealth University, Richmond, VA, USA.
Pokaż więcej
Źródło :
American heart journal [Am Heart J] 2020 Feb; Vol. 220, pp. 246-252. Date of Electronic Publication: 2019 Oct 20.
Typ publikacji :
Clinical Trial Protocol; Journal Article
Journal Info :
Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am. Heart J. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Randomized Controlled Trials as Topic*
Cardiomyopathies/*drug therapy
Glucocorticoids/*administration & dosage
Methotrexate/*administration & dosage
Prednisone/*administration & dosage
Sarcoidosis/*drug therapy
Cardiomyopathies/complications ; Drug Administration Schedule ; Drug Therapy, Combination ; Equivalence Trials as Topic ; Glucocorticoids/adverse effects ; Humans ; Multicenter Studies as Topic ; Prednisone/adverse effects ; Prospective Studies ; Quality of Life ; Research Design ; Sarcoidosis/complications
Czasopismo naukowe
Tytuł :
Connective Tissue is the Issue: Relapsing Polychondritis.
Autorzy :
Murthy VK; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: .
Fava A; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
Pokaż więcej
Źródło :
The American journal of medicine [Am J Med] 2020 Feb; Vol. 133 (2), pp. 195-197. Date of Electronic Publication: 2019 Jul 09.
Typ publikacji :
Case Reports; Journal Article
Journal Info :
Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0267200 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-7162 (Electronic) Linking ISSN: 00029343 NLM ISO Abbreviation: Am. J. Med. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Polychondritis, Relapsing/*diagnosis
Polychondritis, Relapsing/*drug therapy
Prednisone/*therapeutic use
Adult ; Anti-Inflammatory Agents/administration & dosage ; Humans ; Male ; Prednisone/administration & dosage
Czasopismo naukowe
Tytuł :
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
Autorzy :
Mateos MV; Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain. Electronic address: .
Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
Blade J; Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.
Knop S; Würzburg University Medical Center, Würzburg, Germany.
Doyen C; CHU UCL Namur, Université catholique de Louvain, Yvoir, Belgium.
Lucio P; Champalimaud Centre for the Unknown, Lisbon, Portugal.
Nagy Z; 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
Pour L; University Hospital Brno, Brno, Czech Republic.
Cook M; University Hospitals Birmingham NHS Trust, Birmingham, UK.
Grosicki S; Department of Hematology and Cancer Prevention, Chorzów School of Public Health, Medical University of Silesia, Katowice, Poland.
Crepaldi A; Clínica de tratamento e pesquisa em Hematologia e Oncologia, Cuiaba, Brazil.
Liberati AM; Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
Campbell P; Andrew Love Cancer Centre, Geelong, Australia.
Shelekhova T; Clinic of Professional Pathology, Saratov, Russia.
Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Iosava G; Medinvent Institute of Health, Tbilisi, Georgia.
Fujisaki T; Matsuyama Red Cross Hospital, Matsuyama, Japan.
Garg M; Department of Haematology, Leicester Royal Infirmary, Leicester, UK.
Krevvata M; Janssen Research & Development, Spring House, PA, USA.
Chen Y; Janssen Research & Development, Raritan, NJ, USA.
Wang J; Janssen Research & Development, Raritan, NJ, USA.
Kudva A; Janssen Research & Development, Raritan, NJ, USA.
Ukropec J; Janssen Global Medical Affairs, Horsham, PA, USA.
Wroblewski S; Janssen Research & Development, Spring House, PA, USA.
Qi M; Janssen Research & Development, Spring House, PA, USA.
Kobos R; Janssen Research & Development, Raritan, NJ, USA.
San-Miguel J; Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Pamplona, Spain.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Jan 11; Vol. 395 (10218), pp. 132-141. Date of Electronic Publication: 2019 Dec 10.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info :
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Antibodies, Monoclonal/*administration & dosage
Bortezomib/*administration & dosage
Melphalan/*administration & dosage
Multiple Myeloma/*drug therapy
Prednisone/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Asia ; Bortezomib/adverse effects ; Disease-Free Survival ; Drug Administration Schedule ; Drug Therapy, Combination/adverse effects ; Europe ; Female ; Humans ; Maintenance Chemotherapy ; Male ; Melphalan/adverse effects ; Middle Aged ; Multiple Myeloma/mortality ; North America ; Prednisone/adverse effects ; South America ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Empirical treatment of massive lymphadenopathy in a child with mixed type histiocytosis in Kenya.
Autorzy :
Muma S; Outpatient and Emergency Department, AIC Kijabe Hospital, Kijabe, Kenya.
Brotherton BJ; Outpatient and Emergency Department, AIC Kijabe Hospital, Kijabe, Kenya.
Halestrap P; Outpatient and Emergency Department, AIC Kijabe Hospital, Kijabe, Kenya. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2020 Jan 04; Vol. 395 (10217), pp. e1.
Typ publikacji :
Case Reports; Journal Article
Journal Info :
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Histiocytosis/*drug therapy
Prednisone/*administration & dosage
Vinblastine/*administration & dosage
Child, Preschool ; Diagnosis, Differential ; Drug Administration Schedule ; Histiocytosis/diagnostic imaging ; Histiocytosis/pathology ; Humans ; Kenya ; Lymphatic Diseases/diagnostic imaging ; Lymphatic Diseases/drug therapy ; Lymphatic Diseases/pathology ; Male ; Prednisone/therapeutic use ; Sentinel Lymph Node Biopsy ; Tomography, X-Ray Computed ; Treatment Outcome ; Vinblastine/therapeutic use
Czasopismo naukowe
Tytuł :
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.
Autorzy :
George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.; Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina.
Halabi S; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.; Department of Biostatistics, Duke University, Durham, North Carolina.
Healy P; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.; Department of Biostatistics, Duke University, Durham, North Carolina.
Barak I; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.; Department of Biostatistics, Duke University, Durham, North Carolina.
Winters C; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
Anand M; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
Wilder R; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
Klein M; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
Martinez E; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
Nixon AB; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.; Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina.
Harrison MR; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.; Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina.
Szmulewitz R; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.; Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina.
Pokaż więcej
Źródło :
The Prostate [Prostate] 2019 Nov; Vol. 79 (15), pp. 1752-1761. Date of Electronic Publication: 2019 Sep 09.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info :
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Docetaxel/*therapeutic use
Prednisone/*therapeutic use
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Pyrimidines/*therapeutic use
Sulfonamides/*therapeutic use
Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Docetaxel/administration & dosage ; Docetaxel/adverse effects ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Progression-Free Survival ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Pyrimidines/administration & dosage ; Pyrimidines/adverse effects ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment.
Autorzy :
Lee SR; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Choi H; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Lee BH; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Kang KW; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Yu ES; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Kim DS; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Park Y; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Choi CW; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Kim BS; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Sung HJ; Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło :
The Korean journal of internal medicine [Korean J Intern Med] 2019 Nov; Vol. 34 (6), pp. 1333-1346. Date of Electronic Publication: 2018 Oct 26.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
Journal Info :
Publisher: Korean Association of Internal Medicine Country of Publication: Korea (South) NLM ID: 8712418 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-6648 (Electronic) Linking ISSN: 12263303 NLM ISO Abbreviation: Korean J. Intern. Med. Subsets: MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Bortezomib/*administration & dosage
Melphalan/*administration & dosage
Multiple Myeloma/*drug therapy
Prednisone/*administration & dosage
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bortezomib/adverse effects ; Disease Progression ; Female ; Humans ; Male ; Melphalan/adverse effects ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Prednisone/adverse effects ; Progression-Free Survival ; Republic of Korea ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Urinary excretion profile of prednisone and prednisolone after different administration routes.
Autorzy :
Mazzarino M; Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Largo Giulio Onesti, 1, 00197, Rome, Italy.
Piantadosi C; Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Largo Giulio Onesti, 1, 00197, Rome, Italy.
Comunità F; Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Largo Giulio Onesti, 1, 00197, Rome, Italy.
de la Torre X; Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Largo Giulio Onesti, 1, 00197, Rome, Italy.
Botrè F; Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Largo Giulio Onesti, 1, 00197, Rome, Italy.; Dipartimento di Medicina Sperimentale, 'Sapienza' Università di Roma, Viale Regina Elena 324, 00161, Rome, Italy.
Pokaż więcej
Źródło :
Drug testing and analysis [Drug Test Anal] 2019 Nov; Vol. 11 (11-12), pp. 1601-1614. Date of Electronic Publication: 2019 Dec 18.
Typ publikacji :
Journal Article
Journal Info :
Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101483449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-7611 (Electronic) Linking ISSN: 19427603 NLM ISO Abbreviation: Drug Test Anal Subsets: MEDLINE
MeSH Terms :
Glucocorticoids/*urine
Prednisolone/*urine
Prednisone/*urine
Administration, Oral ; Administration, Topical ; Adult ; Chromatography, Liquid/methods ; Glucocorticoids/administration & dosage ; Humans ; Male ; Prednisolone/administration & dosage ; Prednisone/administration & dosage ; Spectrometry, Mass, Electrospray Ionization/methods ; Tandem Mass Spectrometry/methods
Czasopismo naukowe
Tytuł :
High-dose prednisone therapy for infantile spasms and late-onset epileptic spasms in China: The addition of topiramate provides no benefit.
Autorzy :
Yi Z; Department of Pediatric Neurology, Jiangxi Children's Hospital, 122 Yangming Road, Nanchang, Jiangxi Province, PR China.
Wu H; Department of Pediatric Neurology, Jiangxi Children's Hospital, 122 Yangming Road, Nanchang, Jiangxi Province, PR China.
Yu X; Department of Pediatric Neurology, Jiangxi Children's Hospital, 122 Yangming Road, Nanchang, Jiangxi Province, PR China.
Zha J; Department of Pediatric Neurology, Jiangxi Children's Hospital, 122 Yangming Road, Nanchang, Jiangxi Province, PR China.
Chen H; Department of Pediatric Neurology, Jiangxi Children's Hospital, 122 Yangming Road, Nanchang, Jiangxi Province, PR China.
Chen Y; Department of Pediatric Neurology, Jiangxi Children's Hospital, 122 Yangming Road, Nanchang, Jiangxi Province, PR China.
Zhong J; Department of Pediatric Neurology, Jiangxi Children's Hospital, 122 Yangming Road, Nanchang, Jiangxi Province, PR China. Electronic address: .
Pokaż więcej
Źródło :
Seizure [Seizure] 2019 Oct; Vol. 71, pp. 174-178. Date of Electronic Publication: 2019 Jul 17.
Typ publikacji :
Comparative Study; Journal Article
Journal Info :
Publisher: Elsevier Country of Publication: England NLM ID: 9306979 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2688 (Electronic) Linking ISSN: 10591311 NLM ISO Abbreviation: Seizure Subsets: MEDLINE
MeSH Terms :
Outcome Assessment, Health Care*
Anticonvulsants/*pharmacology
Glucocorticoids/*pharmacology
Prednisone/*pharmacology
Spasms, Infantile/*drug therapy
Topiramate/*pharmacology
Age of Onset ; Anticonvulsants/administration & dosage ; Child, Preschool ; Drug Therapy, Combination ; Female ; Glucocorticoids/administration & dosage ; Humans ; Infant ; Male ; Prednisone/administration & dosage ; Topiramate/administration & dosage
Czasopismo naukowe
Tytuł :
Clinical, clinicopathologic, and gastrointestinal changes from administration of clopidogrel, prednisone, or combination in healthy dogs: A double-blind randomized trial.
Autorzy :
Whittemore JC; The Department of Small Animal Clinical Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee.
Mooney AP; The Department of Small Animal Clinical Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee.
Price JM; The Office of Information Technology, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee.
Thomason J; The Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 2019 Nov; Vol. 33 (6), pp. 2618-2627. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article; Randomized Controlled Trial, Veterinary
Journal Info :
Publisher: Wiley Periodicals Country of Publication: United States NLM ID: 8708660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-1676 (Electronic) Linking ISSN: 08916640 NLM ISO Abbreviation: J. Vet. Intern. Med. Subsets: MEDLINE
MeSH Terms :
Clopidogrel/*adverse effects
Platelet Aggregation Inhibitors/*adverse effects
Prednisone/*pharmacology
Stomach Ulcer/*veterinary
Animals ; Clopidogrel/administration & dosage ; Dogs ; Double-Blind Method ; Drug Therapy, Combination ; Gastrointestinal Hemorrhage/chemically induced ; Gastrointestinal Hemorrhage/veterinary ; Glucocorticoids/administration & dosage ; Glucocorticoids/pharmacology ; Platelet Aggregation Inhibitors/administration & dosage ; Prednisone/administration & dosage ; Stomach Ulcer/chemically induced
Czasopismo naukowe
Tytuł :
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study.
Autorzy :
Oh SY; Department of Internal Medicine, Dong-A University Hospital, Busan, 49201, Republic of Korea.
Kim WS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
Kim SJ; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea.
Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, 05505, Republic of Korea.
Yang DH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, 58128, Republic of Korea.
Lee WS; Department of Hematology, Busan Paik Hospital, Inje University College of Medicine, Busan, 04511, Republic of Korea.
Kim HJ; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, 14068, Republic of Korea.
Yhim HY; Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, 54907, Republic of Korea.
Jeong SH; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea.
Won JH; Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, 04401, Republic of Korea.
Lee S; Department of Internal Medicine, Dong-A University Hospital, Busan, 49201, Republic of Korea.
Kong JH; Division of Hematology-Oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, 26426, Republic of Korea.
Lim SN; Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, 48108, Republic of Korea.
Ji JH; Division of Hematology and Oncology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 51353, Republic of Korea.
Kwon KA; Division of Hematology-Oncology, Department of Internal Medicine, Dongnam Institute of Radiological and Medical Sciences, Busan, 46033, Republic of Korea.
Lee GW; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, 52727, Republic of Korea.
Lee JH; Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, 21565, Republic of Korea.
Lee HS; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, 49267, Republic of Korea.
Shin HJ; Division of Oncology, Department of Internal Medicine, Pusan National University Hospital, Busan, 49241, Republic of Korea.
Suh C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, 05505, Republic of Korea. .
Pokaż więcej
Źródło :
Cancer communications (London, England) [Cancer Commun (Lond)] 2019 Oct 16; Vol. 39 (1), pp. 58. Date of Electronic Publication: 2019 Oct 16.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: Electronic Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Cyclophosphamide/*administration & dosage
Lymphoma, B-Cell, Marginal Zone/*drug therapy
Prednisone/*administration & dosage
Rituximab/*administration & dosage
Vincristine/*administration & dosage
Adult ; Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/adverse effects ; Female ; Humans ; Lymphoma, B-Cell, Marginal Zone/mortality ; Male ; Middle Aged ; Prednisone/adverse effects ; Rituximab/adverse effects ; Survival Analysis ; Treatment Outcome ; Vincristine/adverse effects
Czasopismo naukowe
Tytuł :
Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study.
Autorzy :
Prasad D; Departments of Pediatric Gastroenterology.
Poddar U; Departments of Pediatric Gastroenterology.
Kanaujia V; Ophthalmology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Yachha SK; Departments of Pediatric Gastroenterology.
Srivastava A; Departments of Pediatric Gastroenterology.
Pokaż więcej
Źródło :
Journal of glaucoma [J Glaucoma] 2019 Oct; Vol. 28 (10), pp. 929-933.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9300903 Publication Model: Print Cited Medium: Internet ISSN: 1536-481X (Electronic) Linking ISSN: 10570829 NLM ISO Abbreviation: J. Glaucoma Subsets: MEDLINE
MeSH Terms :
Glucocorticoids/*adverse effects
Hepatitis, Autoimmune/*drug therapy
Intraocular Pressure/*drug effects
Ocular Hypertension/*chemically induced
Prednisone/*adverse effects
Administration, Oral ; Adolescent ; Antihypertensive Agents/therapeutic use ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Glucocorticoids/therapeutic use ; Humans ; Male ; Ocular Hypertension/drug therapy ; Prednisone/therapeutic use ; Prospective Studies ; Tonometry, Ocular ; Visual Acuity
Czasopismo naukowe
Tytuł :
Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways.
Autorzy :
Wang X; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Qi D; Department of Nephrology, Yu-Huang-Ding Hospital/Qingdao University, 264000, Yantai, Shandong, PR China.
Fu F; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Li X; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Liu Y; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Ji K; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Gao Z; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Kong L; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Yu C; Medical Research Center, Binzhou Medical University, 264003, Yantai, Shandong, PR China.
Xie H; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Yue G; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Zhu H; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Liu K; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China.
Fan H; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, PR China. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmacology [Eur J Pharmacol] 2019 Sep 05; Vol. 858, pp. 172342. Date of Electronic Publication: 2019 May 23.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur. J. Pharmacol. Subsets: MEDLINE
MeSH Terms :
Angiopoietin-like 4 Protein/*metabolism
Caffeic Acids/*pharmacology
Heme Oxygenase (Decyclizing)/*metabolism
Lactates/*pharmacology
NF-E2-Related Factor 2/*metabolism
PPAR gamma/*metabolism
Prednisone/*pharmacology
Proteinuria/*drug therapy
Animals ; Caffeic Acids/therapeutic use ; Drug Interactions ; Lactates/therapeutic use ; Male ; Mice ; Oxidative Stress/drug effects ; Podocytes/drug effects ; Podocytes/pathology ; Prednisone/therapeutic use ; Proteinuria/metabolism ; Proteinuria/pathology ; Rats
Czasopismo naukowe
Tytuł :
Clinical, clinicopathologic, and gastrointestinal changes from aspirin, prednisone, or combination treatment in healthy research dogs: A double-blind randomized trial.
Autorzy :
Whittemore JC; The Department of Small Animal Clinical Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee.
Mooney AP; The Department of Small Animal Clinical Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee.
Price JM; The Office of Information Technology, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee.
Thomason J; The Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi.
Pokaż więcej
Źródło :
Journal of veterinary internal medicine [J Vet Intern Med] 2019 Sep; Vol. 33 (5), pp. 1977-1987. Date of Electronic Publication: 2019 Aug 08.
Typ publikacji :
Journal Article; Randomized Controlled Trial, Veterinary
Journal Info :
Publisher: Wiley Periodicals Country of Publication: United States NLM ID: 8708660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-1676 (Electronic) Linking ISSN: 08916640 NLM ISO Abbreviation: J. Vet. Intern. Med. Subsets: MEDLINE
MeSH Terms :
Aspirin/*adverse effects
Drug Therapy, Combination/*adverse effects
Gastrointestinal Hemorrhage/*veterinary
Prednisone/*adverse effects
Administration, Oral ; Animals ; Aspirin/administration & dosage ; Dogs ; Double-Blind Method ; Female ; Gastric Mucosa/drug effects ; Gastric Mucosa/pathology ; Gastrointestinal Hemorrhage/chemically induced ; Male ; Prednisone/administration & dosage
Czasopismo naukowe
Tytuł :
Randomized controlled trial on immunomodulatory effects of azithromycin in children with steroid-dependent nephrotic syndrome.
Autorzy :
Sawires H; Pediatric Nephrology Center, Cairo University, Cairo, Egypt. .; Pediatric Nephrology & Transplantation Center, 5 El-Lithy Street El-Maadi El-Gedida, Cairo, 11435, Egypt. .
Abdelaziz H; Pediatric Nephrology Center, Cairo University, Cairo, Egypt.
Ahmed HM; Pediatric Nephrology Department, Beni Suef University, Beni Suef, Egypt.
Botrous O; Pediatric Nephrology Department, Beni Suef University, Beni Suef, Egypt.
Agban M; Microbiology Department, Assiut University, Assiut, Egypt.
Pokaż więcej
Źródło :
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2019 Sep; Vol. 34 (9), pp. 1591-1597. Date of Electronic Publication: 2019 May 15.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info :
Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr. Nephrol. Subsets: MEDLINE
MeSH Terms :
Azithromycin/*pharmacology
Immunologic Factors/*pharmacology
Immunomodulation/*drug effects
Nephrotic Syndrome/*drug therapy
Prednisone/*pharmacology
Azithromycin/therapeutic use ; Child ; Drug Therapy, Combination/methods ; Female ; Follow-Up Studies ; Humans ; Immunologic Factors/therapeutic use ; Male ; Nephrotic Syndrome/blood ; Nephrotic Syndrome/immunology ; Prednisone/therapeutic use ; Treatment Outcome ; Tumor Necrosis Factor-alpha/blood ; Tumor Necrosis Factor-alpha/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies